“The best biotech companies offer a nice balance between several established drugs bringing the company consistent income along with a robust pipeline of potential blockbuster drugs. However, investing in emerging biotech companies can also pay off in a big way if you can stomach the volatility,” advises the author of today’s article before proceeding to highlight three biotech stocks with significant long-term upside to watch in December. For these three biotech stocks – two of which pay dividends and one that’s “a high-risk investment that could become a massive winner” – CLICK HERE.